Presented by
Management Forum
This course is designed to help understand pharmacovigilance quality management systems (QMS) and risk-based audits.
18-19 Nov 2021 + 2 more dates
Since the introduction of the new pharmacovigilance legislation in the EU, QMS and self-audits have become an increasingly important topic. Companies have been challenged by regulators to implement risk-based audits where continual improvement of processes, systems and compliance to regulations needs to be demonstrated. This is required from the top of the company organisation in all areas of regulatory activity including clinical, pharmacovigilance, sales and marketing, IT and medical services.
This must-attend course will explain principles, approaches and regulatory expectations for the pharmacovigilance QMS and risk-based audits and has been designed to help in both the assessments of risk and the whole CAPA process. The highly participative programme will include a mix of presentations from our expert trainer, reallife case studies and practical workshop sessions which will help consolidate learning.
Benefits of attending:
QA representatives, EU QPPVs and all working in pharmacovigilance, regulatory, clinical and administrators responsible for the management of the CAPA systems.
You will be asked to design the QMS for a safety department that has recently been audited. You will need to devise a plan based on any risk elements and audit findings identified and look at designing a QMS approach with KPIs.
You will be presented with a series of findings from a regulatory inspection. You will have to look at the findings and work out priorities, devise root cause analyses and provide detailed CAPA plans which will include QMS activities.
Graeme Ladds, Director of PharSafer, has over 30 years’ experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, he went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his consultancy and specialist CRO company, PharSafer Associates Ltd, where he has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
18-19 Nov 2021
Live online
09:00-16:15 UK (London) (UTC+00)
10:00-17:15 Paris (UTC+01)
04:00-11:15 New York (UTC-05)
Course code 11060
23-24 May 2022
Live online
09:00-16:15 UK (London) (UTC+01)
10:00-17:15 Paris (UTC+02)
04:00-11:15 New York (UTC-04)
Course code 11627
Until 18 Apr
16-17 Nov 2022
Live online
00:00-00:00 UK (London) (UTC+00)
01:00-01:00 Paris (UTC+01)
19:00-19:00 New York (UTC-05)
Course code 11768
Until 12 Oct
The speaker was excellent and gave very practical examples of what is looked for in an Audit
Nov 19 2020
Kathleen Dunphy 
Senior Administrator , NorthStar Healthcare
Nov 11 2019
I wanted to reinforce my knowledge and I definitely accomplished this. Graeme Ladds was great as usual. His pharmacovigilance knowledge is extensive, any question was answered confidently and debate was encouraged.
Christopher Harper 
Senior Medical Information Manager, Astellas Pharma Europe Ltd
Nov 11 2019
The course actually exceeded my expectations and gave me an inside view of flaws in my PhV system. Great speaker with a lot of knowledge, good pace and experiences/stories from real life.
Hrvoje Sarec 
Pharmacovigilance Specialist, Xellia d.o.o.
Nov 11 2019
Excellent presentation by a very experienced speaker. The examples provided and the exercises were greatly appreciated.
Anne-Elisabeth Collignon 
Pharmacovigilance Head of PV Quality Assurance, Institut de Recherches Internationales Servier
Nov 11 2019
The speaker was very knowledgeable and easy to approach and I would definitely attend another course that had him as trainer. The practical examples were very useful and the course was interesting, well organised, and had a good balance in terms of content and difficulty.
Claudia Percivalle
Head of Global Regulatory Affairs, Cycle Pharmaceuticals Ltd.
Nov 11 2019
The speaker was very very good and I particularly liked the opportunity to exchange experiences and examples.
Evangelia Tsakiraki 
EU QPPV, Piramal Critical Care B.V.
Nov 22 2018
Very interactive and interesting the speaker has a great knowledge of the subject and respond to all our queries.
Tracy Salamoun 
Regulatory affairs Associate , Union pharmaceutique d’orient sal
Nov 22 2018
A very well knowledgeable presenter in QA and particularly in PV. The content was rich and touched all areas in great detail. The course is very well balanced and anyone (junior to experienced) in QA could understand and learn from the training.
Netsanet Desta-Evers 
Clinical Safety Compliance Specialist, Novimmune SA
Nov 22 2018
[The speaker] was good :) Overall, it was a good class!
Jiwan Park 
QA Associate, Celltrion
UK
Ireland
Spain
Croatia
France
Germany
Czech Republic
Italy
Korea, Republic Of
Lebanon
Netherlands
Slovak Republic
Switzerland
United States of America
Multiple colleagues?
Talk to one of our training experts to discuss how to:
Cookies: we use cookies to deliver the best experience to you and to help us understand our customers.
